Business Daily Media

The Times Real Estate

.

Marketing application of BOGUTAI® (teriparatide injection) has been officially accepted by the China National Medical Products Administration (NMPA)

HONG KONG SAR - EQS Newswire - 29 June 2022 - A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (the "Company", together with its subsidiaries, the "Group"; Stock code: 00690.HK) is pleased to announce that t the marketing application submitted by the Group's self-developed BOGUTAI® (teriparatide injection) has been accepted by the China National Medical Products Administration ("NMPA") on 28 June 2022, with the acceptance number "CXSS2200062国".

If BOGUTAI® is approved for marketing, it will provide patients with better drug choices, which is a major milestone for the company in the field of orthopedic diseases.

BOGUTAI® (teriparatide injection) is the Group's fifth marketed product following GENETIME® , GENESOFT® , PINUP® , BOKANGTAI®, and it is also the first domestic manufactured PTH Liquid in China to use a disposable injection pen. Developed in collaboration with Swiss self-care giant Ypsomed, this product has an extremely thin injection needle and high dose accuracy, which can greatly reduce the pain of injections for patients. The Group strongly believe BOGUTAI® will be a future blockbuster for the Group by virtue of the product's strong cost advantage, better therapeutic effect and convenient administration method.

Teriparatide injection adopts biological expression technology, and is a recombinant human parathyroid hormone analog (PTH1-34), which has the same sequence as the 34-amino acid N-terminal amino acid (biologically active region) of human parathyroid hormone of 84 amino acids. For the treatment of osteoporosis in postmenopausal women with a high risk of fractures, it is the only osteogenesis-promoting anti-osteoporosis drug approved for marketing at home and abroad, which can effectively improve bone microstructure, increase bone strength, promote bone healing, and significantly reduce the risk of vertebral and nonvertebral fractures in postmenopausal women.

China is the country with the largest number of osteoporosis in the world. According to the data of the seventh census in 2021, there are currently 264.02 million people aged 60 and above in my country, accounting for 18.70%. Epidemiological surveys show that the prevalence of osteoporosis among people over 50 years old in China is 20.7% for women and 14.4% for men; the prevalence of osteoporosis among people over 60 years old is significantly higher, and women are particularly prominent, as high as 51.6%. Hence, there are currently about 90 million osteoporosis patients in China, and the osteoporosis market size is about 15 billion to 20 billion yuan. The current market share of teriparatide is only about 1% of the PRC osteoporosis market, which is significantly lower than that of foreign countries. The main reason is that it is expensive and not covered by medical insurance. However, in the long run, with the aging of Chinese's population, the gradual improvement of the coverage of the medical insurance system and the improvement of residents' purchasing power, the market size of teriparatide will accelerate significant. Moreover, BOGUTAI's product positioning of being more cost-effective and safe fits the needs of target demographic better, ensuring faster growth compared to other teriparatide competitors.

About Uni-Bio Science Group

Uni-Bio Science Group Limited is principally engaged in the research and development, manufacture and distribution of biopharmaceutical products. The research and development center is fully equipped with a complete system for the development of genetically-engineered products with a pilot plant test base which is in line with NMPA requirements. The Group has two GMP manufacturing bases in Beijing and Shenzhen. The Group also has a highly efficient commercialization platform and marketing network. The Group focuses on the development of novel treatments and innovative drugs addressing the therapeutic areas of endocrine as diabetes and osteoporosis, ophthalmology and dermatology. Please visit the official website of Uni-Bio Science Group for more information:

#UniBioScienceGroup

News from Asia

Championing European Culinary Heritage in Hong Kong

HONG KONG SAR - Media OutReach Newswire - 14 May 2025 - ​European culinary delicacies shine this May, as the "Enjoy the Authentic Joy from Europe" campaign celebrates four premium delicatessen mea...

LINE NEXT and Kaia Expand Web3 and Stablecoin Adoption Across Asia Following a Native Deployment of Tether’s USD₮ on Kaia Blockchain

ABU DHABI, UAE - Media OutReach Newswire - 14 May 2025 - Tether, the largest company in the digital assets industry announced it has created a native deployment of Tether's USD₮ on the Kaia bloc...

Hang Lung’s NET•WORK Captures New Office Demand Wave: Landlord-Managed Space Hits 70% Occupancy

HONG KONG SAR - Media OutReach Newswire - 14 May 2025 - Hang Lung Properties Limited (SEHK Stock Code: 00101) (the "Company" or "Hang Lung") is pleased to announce the launch of NET•WORK, a premie...

Bora Pharmaceuticals Exits Integration Phase with Sequentially-Improved Gross and Operating Margins

Positioned to Unlock M&A Value through U.S. Manufacturing Amidst Geopolitical Complexities and Specialty Portfolio HONG KONG SAR - Media OutReach Newswire - 14 May 2025 - Bora Pharmaceuticals ...

Johnson Electric Hosts 2025 Humanoid Roundtable to Explore Hardware Standards in Next-Generation Humanoid Robotics

Leaders from seven humanoid manufacturers convene with hardware experts to discuss the future of humanoid hardware standardization VANDALIA, OHIO - Media OutReach Newswire - 14 May 2025 - Johnson...

The Chinese and French children's choirs have another musical rendezvous in Paris

WUZHISHAN, CHINA - Media OutReach Newswire - 14 May 2025 - May is a great season to experience the French romance. Nearly 20 members of the Wuzhishan Li & Miao Children's Choir once again set ...

Prof Dr Klemens Joos back as CEO of the EUTOP Group

BRUSSELS, BELGIUM - Newsaktuell - 14 May 2025 - Prof Dr Klemens Joos (56) has been back at the helm of the EUTOP Group as CEO since 13 May 2025.

Intermittent Hypoxia-Hyperoxia Therapy (IHHT) Launched: Breakthrough Breathing Therapy for Heart, Brain, and Healthy Aging

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 14 May 2025 - Ai Mediq SA today officially launched Intermittent Hypoxia-Hyperoxia Therapy (IHHT), a science-backed, non-invasive breathing thera...

Cyberport Hosts "AI x Cybersecurity Forum"

Exploring the Risks and Opportunities of AI Applications in Cybersecurity HONG KONG SAR - Media OutReach Newswire - 14 May 2025 - Co-organised by Cyberport and the Hong Kong Cybersecurity Professi...

CGTN: Peng Liyuan and Brazil's first lady visit NCPA in Beijing, vow to deepen cultural exchange

BEIJING, CHINA - Media OutReach Newswire - 14 May 2025 - The National Centre for the Performing Arts (NCPA) in Beijing on Tuesday welcomed Peng Liyuan, wife of Chinese President Xi Jinping, and Ro...

Deputy Unveils Enterprise-Grade Analytics+ to Power Smarter Workforce Decisions for Shift-Based Businesses

Deputy, the world’s leading workforce management platform for shift work, today announced the global launch of Deputy Analytics+, a next-generatio...

UNSW startup accelerator offers $200K to the next generation of Australian deeptech unicorns

UNSW Founders, Australia’s most recommended startup accelerator, has partnered with fund manager Luminary Partners to invest $200,000 each into 18...

The Future Is Now: AI Modernization Is Reshaping How Business Gets Done

The present business environment imposes stronger requirements on Australian organizations to match the fast-paced digital-first economy requireme...

Businesses losing an average of $493k from data integrity flaws

Managing data responsibly and effectively for the AI age can give organisations a strong competitive advantage, but many are failing to harness th...

AI shopping disruptor Zyft raises $7.5M to lead the next gen of retail tech

Zyft appoints new CEO, Richard Stevens, to lead the latest Waller Group success story, valued at $30 million SYDNEY, 28 April 2025: Zyft, the lea...

Little known law offers savvy Kiwis the opportunity to supercharge their retirement savings

A little-known legal amendment is being leveraged by savvy New Zealanders and expat Brits to supercharge their retirement savings. Not many peop...

Sell by LayBy